01 /
Target Identification
AI helps in finding new biological targets for drugs.
High-Throughput Data Analysis
Pattern Recognition and Predictive Power
Learn More
02 /
AI-powered Drug Discovery and Design
AI screens large libraries of compounds for potential therapeutic effects.
Enhanced Efficiency and Speed
Predictive Analytics
Learn More
03 /
Drug Repositioning and Repurposing
Finding new uses for existing drugs with AI analysis and Repurposing existing drugs for new therapeutic indications using AI.
AI techniques can leverage insights from multilevel biological systems and drug development pipelines to create more robust models.
AI algorithms significantly expedite drug repositioning and development by integrating biological knowledge, such as the human interactome, organelles, tissues, and organs.
Cost and Time Efficiency
Enhanced Patient Accessibility
Learn More
04 /
AI-enhanced API Discovery / AI-API
AI-enhanced discovery of Active Pharmaceutical Ingredients (APIs) and APIs designed.
Enhanced Efficiency
De Novo Design
Learn More
Target Identification
AI-Powered Drug Discovery and Design
Drug Repositioning and Repurposing
AI-enhanced API Discovery / AI-API
01 / Traditional Synthesizer VS AI-synthesizer
02 / AI-synthesizer for Small Molecule Drugs
03 / AI-synthesizer for Antibody Drug Conjugates
Traditional Synthesizer VS AI-synthesizer
AI-synthesizer for Small Molecule Drugs
AI-synthesizer for Antibody Drug Conjugates
01 / AI-assisted Drug High Throughput Screening (in vitro HTS)
AI aids in screening existing FDA-approved drug pools as well as newly designed drug libraries to identify potential therapeutic candidates.
Cost and Time Efficiency
Safety Profile Known
Learn More
02 / Discovering New Materials
AI-driven screening for materials with specific properties, including catalysts, polymers, and nanomaterials.
Data-Driven Discovery
Virtual Screening
Learn More
03 / AI for Sustainable Development
Screening chemicals that can degrade pollutants or toxins, contributing to environmental sustainability.
In the pursuit of achieving the United Nations' Sustainable Development Goals (SDGs), integrating AI into healthcare emerges as a critical and transformative strategy.
AI has the potential to revolutionize global healthcare, contributing significantly to several key aspects aligned with the SDGs.
Efficiency in Data Analysis
Integration of Multidisciplinary Data
Learn More
Screening for compounds with anti-aging, moisturizing, or other beneficial properties for cosmetic products.
Optimization of Formulations
Safety and Efficacy Assessment
Learn More
05 / Diagnostic Tool Development
AI-assisted development of diagnostic tools for rapid screening of disease biomarkers.
Enhanced Diagnostic Accuracy
Predictive Analytics
Learn More
AI-assisted Drug High Throughput Screening (in vitro HTS)
Discovering New Materials
AI for Sustainable Development
Cosmetic Screening
Diagnostic Tool Development
01 / Traditional VS AI-guided
02 / Toxicology and Safety Testing
Traditional VS AI-guided
Toxicology and Safety Testing
01 / Small Nucleic Acid Drugs
The targeted therapeutic approach using small nucleic acids, such as ASO, siRNA, and miRNA, for specific gene modulation to treat diseases.
Predictive Modeling
Cost and Time Efficiency
Learn More
ASO: Antisense Oligonucleotide
siRNA: Small Interfering RNA
miRNA: MicroRNA
LNP and GalNAc delivery systems are advanced technologies designed to enhance the targeted delivery and cellular uptake of small nucleic acid drugs, improving their therapeutic efficacy and safety.
Enhanced Targeting
Personalized Medicine
Learn More
Lipid Nanoparticles (LNP): Encapsulates and protects nucleic acids, enhancing stability and delivery.
GalNAc Conjugation: Targets liver cells (hepatocytes), improving specificity and reducing side effects.
Small Nucleic Acid Drugs
Delivery Systems
01 /
Customize GMP Manufacturing
Tailored GMP manufacturing solutions designed to meet the diverse needs of our clients in the pharmaceutical and biotechnology industries.
Quality Assurance
Innovation and Flexibility
Learn More
02 /
Small Molecule Drug CDMO
Offering tailored synthesis solutions for complex molecules, from milligram to tons at every stage ranging from Pre-clinical to Commercial Production.
Enhanced Efficiency
Increased Selectivity and Specificity
Learn More
03 /
Small Nucleic Acid Drugs CDMO
Synthetic biology technology and liquid phase molecular synthesis technology.
Enhanced Precision
Data-Driven Insights
Learn More
Small nucleotides
Small nucleic acid building blocks
Oligonucleotide chain
04 /
Formulation Development & Scale-Up Production
Comprehensive formulation development and GMP-compliant scale-up production services designed to support the successful transition of your product from concept to market.
Optimized Formulation Selection
Accelerated Development Process
Learn More
05 /
Regulatory Assistance
Tailored services for various regulatory submissions, including Investigational New Drug (IND) applications, New Drug Applications (NDA), Drug Master Files (DMF), and more.
Customized Regulatory Solutions
Simplified Market Access
Learn More
Customize GMP Manufacturing
Small Molecule Drugs CDMO
Small Nucleic Acid Drugs CDMO
Formulation Development & Scale-Up Production
Regulatory Assistance
Privacy Policy |
Cookie Policy |
Copyright © Protheragen-ING. All Rights Reserved.